Arimistane + Enclomiphene

Arimistane + Enclomiphene – Product Information Arimistane + Enclomiphene is a research compound designed to facilitate researchers investigating the Post Research Recovery Protocol. Formulated with Arimistane and Enclomiphene, it aims to support hormone balance and recovery after a cycle of hormonal treatment in research subjects. Arimistane may help mitigate potential estrogen-related issues, while Enclomiphene may support the restoration of natural testosterone production. This comprehensive approach may aid in optimizing hormonal levels, reducing the risk of estrogenic side effects, and facilitating the post-cycle period in research studies. The liquid and tablets consist of two compounds: Arimistane + Enclomiphene . The tablets are offered as 50mg Arimistane + 20mg Enclomiphene per tablet. The liquid is offered as 16,5mg Arimistane + 16.5mg Enclomiphene per liquid vial. Arimistane Arimistane is an aromatase inhibitor, which implies a reduction in the production of estrogen. Aromatase inactivators are bound to the catalytic site, where they are transformed into electrophilic intermediates that become irreversibly attached to the enzyme, blocking its activity. These inhibitors have distinct advantages in compound design because they are highly enzyme-specific, produce prolonged inhibition, and exhibit minimal toxicities. Studies show that Arimistane, as an aromatase inhibitor, effectively delays epiphysial maturation in young subjects and improves testosterone levels in adult subjects by suppressing the production of estrogen. Arimistane CAS Number 1420-49-1 Molar Mass 284.17 g/mol Chemical Formula C19H24O2 IUPAC Name (8R,9S,10R,13S,14S)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-7,17-dione Enclomiphene Enclomiphene is an estrogen receptor (ER) modulator. It acts as an ER antagonist in human subjects, sheep, and rabbits and an ER agonist in rats. Enclomiphene inhibits the binding of 17beta-estradiol in isolated rabbit uterus. It decreases E2-induced inhibition of follicle-stimulating hormone (FSH) secretion in primary sheep pituitary cells in a concentration-dependent manner. Enclomiphene (0.25 and 0.5 mg/animal) inhibits spermatogenesis and decreases serum luteinizing hormone (LH) and testosterone levels in intact or castrated rats. Formulations containing enclomiphene have been used in the treatment of ovarian dysfunction. Enclomiphene is being studied for its potential to increase serum total testosterone levels while maintaining sperm counts in the normal range in male subjects with secondary hypogonadism. Enclomiphene CAS Number 7599-79-3 Molar Mass 598.1 g/mol Chemical Formula C32H36ClNO8 IUPAC Name 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Disclaimer This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR LABORATORY AND RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC), following the guidelines of the Animal Welfare Act (AWA). Our content is intended to be used and must be used for informational purposes only. It is very important to do your analysis and research from Trusted Sources before making any purchase based on your circumstances. You should independently research and verify any information that you find on our Website and wish to rely upon. By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority – if you are not 100% satisfied with the product you received, please contact us at support@purerawz.co ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human usage.